Related Experiment Video
Updated: May 15, 2026
10:33
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
[Acarbose and propofol: a dangerous combination?]
E Rocha-Honor1, F J Polo-Romero1, P Sánchez-Beteta1
1Servicio de Medicina Interna, Hospital de Hellín, Hellín, Albacete, España.
Revista Espanola De Anestesiologia Y Reanimacion
|January 2, 2013
Summary
Propofol can cause rare but serious liver injury (hepatotoxicity). This case highlights a potential interaction with acarbose, emphasizing careful pre-anesthetic evaluation for patients receiving propofol sedation.
Area of Science:
- Hepatology
- Anesthesiology
- Pharmacology
Background:
- Propofol is widely used for sedation in various procedures, including endoscopy and surgery.
- Hepatotoxicity is a rare but serious adverse effect of propofol.
- Acarbose is a common medication for type 2 diabetes management.
Observation:
- A case report details a patient who developed acute hepatitis after propofol use during ophthalmology surgery.
- The patient had a history of acarbose use, a drug also known to cause liver injury.
- This suggests a potential synergistic or additive hepatotoxic effect between propofol and acarbose.
Findings:
- The patient's acute hepatitis was diagnosed early and resolved without complications.
- This case underscores the importance of considering concurrent medications when assessing propofol-induced hepatotoxicity.
- The interaction between propofol and acarbose in causing hepatitis warrants further investigation.
Implications:
- Enhanced pre-anesthetic evaluation is crucial for patients undergoing propofol sedation, especially those on medications like acarbose.
- Early recognition and diagnosis of propofol-induced hepatotoxicity are key to successful management.
- This case contributes to understanding rare drug-induced liver injury and informs clinical practice for patient safety.
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...